Vyvanse 40 MG capsule 100S
Ended Awarded
- Contract number
- SPE2DB25FEZL8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,784
Award facts
- Contract value 100% obligated
- $1,783.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,783.60 for 100 capsules of Vyvanse 40 mg on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Vyvanse (lisdexamfetamine dimesylate) is a prescription stimulant medication commonly used to treat attention-deficit/hyperactivity disorder and binge eating disorder within the military healthcare system.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle extending through December 2026. The IDC serves as a global sourcing mechanism enabling the company to deliver a broad range of brand-name and generic pharmaceuticals, vaccines, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. As a major pharmaceutical distributor and critical vendor in the federal medical procurement supply chain, AmerisourceBergen Drug Corp has demonstrated capability to fulfill competitively awarded federal contracts across multiple therapeutic domains while maintaining firm fixed pricing across transaction values ranging from under $100 to orders exceeding $45,000.
Quick answers
Who was awarded contract SPE2DB25FEZL8?
SPE2DB25FEZL8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 24, 2025.
How much is contract SPE2DB25FEZL8 worth?
The government has obligated $1,784 on SPE2DB25FEZL8.
Is contract SPE2DB25FEZL8 an order under another contract?
Yes. SPE2DB25FEZL8 is a delivery order under SPE2DB22D1106, an indefinite delivery contract.
Was contract SPE2DB25FEZL8 competed?
The extent of competition for SPE2DB25FEZL8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award